Scope of this article
This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.
This translation is provided for general access and has no recorded medical-language review.
Editorial general information — not a clinical-review record
Published: Updated: Publisher: Dr. Murat Toktamışoğlu
No universal six-month or annual HIFU retreatment schedule has been established. A repeat decision should follow review of the first treatment's exact device and dose record, adequate assessment time, objective change, a continuing indication, new risks and the person's preferences.
This translation has no recorded clinical or medical-language review.
MFU studies commonly assess outcomes at 90 and 180 days, and sometimes through 12 months. These are research time points; they do not show that an effect starts or lasts identically in every person or that new energy must be delivered on a fixed schedule. Small single-arm long-term studies cannot fully separate natural ageing, weight change and other procedures from treatment response.
The first device, transducer, energy and line record should be available, and baseline and follow-up images should match lighting, angle, focal length and expression. Reassess whether the target remains tissue laxity rather than volume loss, pigment, muscle activity or a concern requiring surgery. Persistent numbness, pain, hollowing, weakness or unexplained asymmetry warrants investigation before another session is planned.
Discuss the limited and variable expected change, no treatment and alternatives, uncertainty about cumulative exposure and a follow-up plan. Lack of meaningful benefit after the first session does not automatically justify higher energy or more frequent treatment. A repeat session should be a separate medical decision based on a renewed indication, not an automatic component of a sales package.
This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.
These links are editorial starting points used to examine the article's boundaries.
Contini M, Hollander MHJ, Vissink A, Schepers RH, Jansma J, Schortinghuis J · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Ling J, Zhao H · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Riopelle AM, Geisler AN, Eber A, Dover JS · 2025
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Niu Z et al. · 2021
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Prospective study authors; Aesthetic Plastic Surgery · 2025
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
M. Amiri et al. · 2025
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
U.S. Food and Drug Administration (FDA) · 2025
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review